Lifestyle and breast cancer recurrences: The DIANA-5 trial

Tumori

Volumn 98, Issue 1, 2012, Pages 1-18

  Villarini, Anna ^a   Pasanisi, Patrizia ^a   Traina, Adele ^b   Mano, Maria Piera ^c   Bonanni, Bernardo ^d   Panico, Salvatore ^e   Scipioni, Corrado ^f   Galasso, Rocco ^g   Paduos, Adriana ^h   Simeoni, Milena ⁱ   Bellotti, Elena ^j   Barbero, Maggiorino ^k   Macellari, Giorgio ^l   Venturelli, Elisabetta ^a   Raimondi, Milena ^a   Bruno, Eleonora ^a   Gargano, Giuliana ^a   Fornaciari, Giuseppe ^a   Morelli, Daniele ^m   Seregni, Ettore ^a   Krogh, Vittorio ^a   Berrino, Franco ^a   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ARNAS Ospedali Civico e Benfratelli G di Cristina e M Ascoli   (Italy)

^c Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica   (Italy)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Centro di Prevenzione Diagnosi e Terapia Del Tumore Alla Mammella Giunone   (Italy)

^g CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^h OSPEDALE DEGLI INFERMI   (Italy)

ⁱ Associazione LUMEN   (Italy)

^j BUSTO ARSIZIO HOSPITAL   (Italy)

^k SOC Ginecologia e Ostetricia   (Italy)

^l Azienda Sanitaria Locale   (Italy)

^m Laboratory Medicine   (Italy)

more..

Author keywords

Breast cancer; Diet; Physical exercise; Randomized trial; Recurrence; Survival

Indexed keywords

ESTROGEN; INSULIN; SOMATOMEDIN; BIOLOGICAL MARKER; SEX HORMONE; SOMATOMEDIN C;

ADULT; ANTHROPOMETRY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; EXERCISE INTENSITY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; LIFESTYLE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MEDITERRANEAN DIET; MULTICENTER STUDY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; TUMOR CLASSIFICATION; AGED; BLOOD; BODY FAT DISTRIBUTION; BREAST TUMOR; CALORIC RESTRICTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENERGY METABOLISM; EXERCISE; ITALY; LYMPH NODE METASTASIS; MEDICAL RECORD; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATIENT COMPLIANCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; TUMOR RECURRENCE;

ADULT; AGED; BIOLOGICAL MARKERS; BODY FAT DISTRIBUTION; BREAST NEOPLASMS; CALORIC RESTRICTION; DIET RECORDS; DIET, MEDITERRANEAN; ENERGY METABOLISM; EXERCISE; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; ITALY; LIFE STYLE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT COMPLIANCE; PROGNOSIS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION;

EID: 84863189700     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1700/1053.11494     Document Type: Article

References (123)

1. Berrino F, De Angelis R, Sant M, Rosso S, Bielska-Lasota M, Coebergh JW, Santaquilani M: Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol, 8: 773-783, 2007. (Pubitemid 47321600)
2. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I: Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol, 8: 784-796, 2007. (Pubitemid 47321601)
3. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet, 351: 1451-1467, 1998.
4. Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R: Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol, 28: 509-518, 2010.
5. Dahabreh IJ, Linardou H, Siannis F, Fountzilas G, Murray S: Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials. Oncologist, 13: 620-630, 2008. (Pubitemid 351904907)
6. Berrino F, Villarini A, De Petris M, Raimondi M, Pasanisi P: Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. Ann N Y Acad Sci, 1089: 110-118, 2006. (Pubitemid 47092078)
7. Rock CL, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Newman VA, Hollenbach KA, Jones L, Caan BJ, Pierce JP: Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol, 23: 6631-6638, 2005. (Pubitemid 46190257)
8. Ingram D: Diet and subsequent survival in women with breast cancer. Br J Cancer, 69: 592-595, 1994.
9. Thomson CA, Rock CL, Thompson PA, Caan BJ, Cussler E, Flatt SW, Pierce JP: Vegetable intake is associated with reduced breast cancer recurrence in tamoxifen users: a secondary analysis from the Women's Healthy Eating and Living Study. Breast Cancer Res Treat, 125: 519-527, 2011.
10. Rock CL, Demark-Wahnefried W: Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol, 20: 3302-3316, 2002. (Pubitemid 34831528)
11. Patterson RE, Cadmus LA, Emond JA, Pierce JP: Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas, 66: 5-15, 2010.
12. Patterson RE, Flatt SW, Newman VA, Natarajan L, Rock CL, Thomson CA, Caan BJ, Parker BA, Pierce JP: Marine fatty acid intake is associated with breast cancer prognosis. J Nutr, 141: 201-206, 2011.
13. Kang X, Zhang Q, Wang S, Huang X, Jin S: Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy. CMAJ, 182: 1857-1862, 2010.
14. Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, Lu W: Soy food intake and breast cancer survival. JAMA, 302: 2437- 2443, 2009.
15. Guha N, Kwan ML, Quesenberry CP Jr, Weltzien EK, Castillo AL, Caan BJ: Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study. Breast Cancer Res Treat, 118: 395-405, 2009.
16. Caan BJ, Natarajan L, Parker B, Gold EB, Thomson C, Newman V, Rock CL, Pu M, Al Delaimy W, Pierce JP: Soy food consumption and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev, 20: 854-858, 2011.
17. McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, Shields PG, Ambrosone CB, Edge SB, Li HF, Kasprzak C, Freudenheim JL: Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. Breast Cancer Res Treat, 122: 229-235, 2010.
18. Sopotsinskaia EB, Balitskii KP, Tarutinov VI, Zhukova VM, Semenchuk DD, Kozlovskaia SG, Grigorov I: Experience with the use of a low-calorie diet in breast cancer patients to prevent metastasis. Vopr Onkol, 38: 592-599, 1992. (Pubitemid 23126372)
19. de Waard F, Ramlau R, Mulders Y, de Vries T, van Waveren S: A feasibility study on weight reduction in obese postmenopausal breast cancer patients. Eur J Cancer Prev, 2: 233-238, 1993.
20. Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, Berselli E, Muti P, Secreto G: Serum testosterone levels and breast cancer recurrence. Int J Cancer, 113: 499-502, 2005. (Pubitemid 40038721)
21. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, Goodman MT, Giuliano AE, Karanja N, McAndrew P, Hudis C, Butler J, Merkel D, Kristal A, Caan B, Michaelson R, Vinciguerra V, Del Prete S, Winkler M, Hall R, Simon M, Winters BL, Elashoff RM: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst, 98: 1767-1776, 2006. (Pubitemid 46017928)
22. Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, Rock CL, Kealey S, Al Delaimy WK, Bardwell WA, Carlson RW, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Madlensky L, Marshall J, Newman VA, Ritenbaugh C, Thomson CA, Wasserman L, Stefanick ML: Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA, 298: 289-298, 2007. (Pubitemid 47080483)
23. McTiernan A, Irwin M, Vongruenigen V: Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol, 28: 4074-4080, 2010.
24. Protani M, Coory M, Martin JH: Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123: 627-635, 2010.
25. Ibrahim EM, Al Homaidh A: Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol, 28: 753-765, 2011.
26. Holick CN, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Bersch AJ, Stampfer MJ, Baron JA, Egan KM, Willett WC: Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev, 17: 379-386, 2008. (Pubitemid 351272790)
27. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA: Physical activity and survival after breast cancer diagnosis. JAMA, 293: 2479-2486, 2005. (Pubitemid 40705729)
28. Holmes MD, Chen WY, Hankinson SE, Willett WC: Physical activity's impact on the association of fat and fiber intake with survival after breast cancer. Am J Epidemiol, 170: 1250-1256, 2009.
29. Kelsey JL, Horn-Ross PL: Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev, 15: 7-16, 1993. (Pubitemid 23269067)
30. World Cancer Research Fund, American Institute for Cancer Research: Food, Nutrition, Physical activity and the Prevention of Cancer: a Global Perspective. Washington DC, AICR, 2007.
31. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, Paskett E, Phillips L, Robbins J, Rossouw JE, Sarto GE, Shikany JM, Stefanick ML, Thomson CA, Van Horn L, Vitolins MZ, Wactawski-Wende J, Wallace RB, Wassertheil-Smoller S, Whitlock E, Yano K, Adams-Campbell L, Anderson GL, Assaf AR, Beresford SA, Black HR, Brunner RL, Brzyski RG, Ford L, Gass M, Hays J, Heber D, Heiss G, Hendrix SL, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Kotchen JM, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Henderson MM: Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA, 295: 629-642, 2006. (Pubitemid 43209065)
32. Sieri S, Krogh V, Ferrari P, Berrino F, Pala V, Thiebaut AC, Tjonneland A, Olsen A, Overvad K, Jakobsen MU, Clavel- Chapelon F, Chajes V, Boutron-Ruault MC, Kaaks R, Linseisen J, Boeing H, Nothlings U, Trichopoulou A, Naska A, Lagiou P, Panico S, Palli D, Vineis P, Tumino R, Lund E, Kumle M, Skeie G, Gonzalez CA, Ardanaz E, Amiano P, Tormo MJ, Martinez-Garcia C, Quiros JR, Berglund G, Gullberg B, Hallmans G, Lenner P, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, van Gils CH, Key TJ, Crowe FL, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Norat T, Riboli E: Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr, 88: 1304-1312, 2008.
33. Thiebaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M, Schatzkin A: Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst, 99: 451-462, 2007. (Pubitemid 47073568)
34. Cottet V, Touvier M, Fournier A, Touillaud MS, Lafay L, Clavel-Chapelon F, Boutron-Ruault MC: Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study. Am J Epidemiol, 170: 1257-1267, 2009.
35. Murtaugh MA, Sweeney C, Giuliano AR, Herrick JS, Hines L, Byers T, Baumgartner KB, Slattery ML: Diet patterns and breast cancer risk in Hispanic and non-Hispanic white women: the Four-Corners Breast Cancer Study. Am J Clin Nutr, 87: 978-984, 2008. (Pubitemid 351549244)
36. Sieri S, Krogh V, Pala V, Muti P, Micheli A, Evangelista A, Tagliabue G, Berrino F: Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev, 13: 567-572, 2004. (Pubitemid 38737892)
37. Trichopoulou A, Bamia C, Lagiou P, Trichopoulos D: Conformity to traditional Mediterranean diet and breast cancer risk in the Greek EPIC (European Prospective Investigation into Cancer and Nutrition) cohort. Am J Clin Nutr, 92: 620-625, 2010.
38. Wu AH, Yu MC, Tseng CC, Stanczyk FZ, Pike MC: Dietary patterns and breast cancer risk in Asian American women. Am J Clin Nutr, 89: 1145-1154, 2009.
39. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst, 98: 1406-1415, 2006. (Pubitemid 44530717)
40. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, Thiebaut A, Tjonneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E: Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst, 97: 755-765, 2005. (Pubitemid 40879595)
41. Micheli A, Muti P, Secreto G, Krogh V, Meneghini E, Venturelli E, Sieri S, Pala V, Berrino F: Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer, 112: 312-318, 2004. (Pubitemid 39244371)
42. Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA: Sex hormones, risk factors, and risk of estrogen re-ceptor-positive breast cancer in older women: a longterm prospective study. Cancer Epidemiol Biomarkers Prev, 14: 1047-1051, 2005. (Pubitemid 40656446)
43. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel- Chapelon F, Fournier A, Thiebaut A, Gonzalez CA, Quiros JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E: Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer, 12: 1071-1082, 2005.
44. Key T, Appleby P, Barnes I, Reeves G: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst, 94: 606-616, 2002. (Pubitemid 34498648)
45. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE: Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst, 96: 1856-1865, 2004. (Pubitemid 40081323)
46. Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K: Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst, 101: 384-398, 2009.
47. Eliassen AH, Hankinson SE: Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol, 630: 148-65, 2008.
48. James RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Mesrine S, Engel P, Clavel-Chapelon F, Chang-Claude J, Vrieling A, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Rodríguez L, Buckland G, Sánchez MJ, Amiano P, Ardanaz E, Bueno-de-Mesquita B, Ros MM, van Gils CH, Peeters PH, Khaw KT, Wareham N, Key TJ, Allen NE, Romieu I, Siddiq A, Cox D, Riboli E, Kaaks R. Cancer Prev Res, 4: 1626-1635, 2011.
49. Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, Evangelista A, Allemani C, Micheli A, Tagliabue G, Schunemann HJ, Menard S, Berrino F, Muti P: Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev, 18: 169-176, 2009.
50. Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, Huang AJ, Vitolins M, Hubbell FA, Manson JE, Cochrane BB, Lane DS, Lee JS: Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst, 103: 562-570, 2011.
51. Ritte RE, Lukanova A, Dossus L, Becker S, Rinaldi S, Tjonneland AA, Olsen A, Overvad KK, Mesrine S, Engel P, Clavel-Chapelon F, Chang-Claude J, Vrieling A, Boeing H, Schutze M, Antonia TA, Lagiou P, Trichopoulos D, Palli D, Krogh V, Panico S, Tumino R, Sacerdote C, Rodriguez L, Buckland G, Sanchez MJ, Amiano P, Ardanaz E, Bueno-de-Mesquita HB, Ros MM, van Gils CH, Peeters PH, Khaw KT, Wareham NJ, Key TJ, Allen NE, Romieu I, Siddiq A, Cox DG, Riboli E, Kaaks R: Postmenopausal serum sex steroids and risk of hormone receptor positive and negative breast cancer: a nested case-control study. Cancer Prev Res (Phila), 2011 [Epub ahead of print].
52. Liao DJ, Dickson RB: Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol, 80: 175-189, 2002. (Pubitemid 34233739)
53. Siiteri PK: Adipose tissue as a source of hormones. Am J Clin Nutr, 45: 277-282, 1987.
54. Vigersky RA, Kono S, Sauer M, Lipsett MB, Loriaux DL: Relative binding of testosterone and estradiol to testos-terone-estradiol-binding globulin. J Clin Endocrinol Metab, 49: 899-904, 1979. (Pubitemid 10171338)
55. Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, Cauley JA, Sutton-Tyrrell K, Robbins J, Fried LP, Cappola AR: Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab, 94: 4776-4784, 2009.
56. Lahmann PH, Hoffmann K, Allen N, van Gils CH, Khaw KT, Tehard B, Berrino F, Tjonneland A, Bigaard J, Olsen A, Overvad K, Clavel-Chapelon F, Nagel G, Boeing H, Trichopoulos D, Economou G, Bellos G, Palli D, Tumino R, Panico S, Sacerdote C, Krogh V, Peeters PH, Bueno-de-Mesquita HB, Lund E, Ardanaz E, Amiano P, Pera G, Quiros JR, Martinez C, Tormo MJ, Wirfalt E, Berglund G, Hallmans G, Key TJ, Reeves G, Bingham S, Norat T, Biessy C, Kaaks R, Riboli E: Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer, 111: 762-771, 2004. (Pubitemid 39062901)
57. Lahmann PH, Schulz M, Hoffmann K, Boeing H, Tjonneland A, Olsen A, Overvad K, Key TJ, Allen NE, Khaw KT, Bingham S, Berglund G, Wirfalt E, Berrino F, Krogh V, Trichopoulou A, Lagiou P, Trichopoulos D, Kaaks R, Riboli E: Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer, 93: 582-589, 2005. (Pubitemid 43080003)
58. Korner A, Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Williams CJ, Kaprara A, Bullen J, Neuwirth A, Tseleni S, Mitsiades N, Kiess W, Mantzoros CS: Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J Clin Endocrinol Metab, 92: 1041-1048, 2007. (Pubitemid 46465681)
59. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, Papadiamantis Y, Markopoulos C, Spanos E, Chrousos G, Trichopoulos D: Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89: 1102-1107, 2004. (Pubitemid 38368397)
60. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, Noguchi S: Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 9: 5699-5704, 2003. (Pubitemid 37499493)
61. Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, Hsu GC, Yu CP, Yu JC, Sun CA: Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer, 14: 669-677, 2007. (Pubitemid 350074056)
62. Tworoger SS, Eliassen AH, Kelesidis T, Colditz GA, Willett WC, Mantzoros CS, Hankinson SE: Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab, 92: 1510-1516, 2007. (Pubitemid 46556432)
63. Friedenreich CM: Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev, 10: 15-32, 2001.
64. McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R: Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol, 21: 1961-1966, 2003. (Pubitemid 46606384)
65. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, Strickler HD: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst, 101: 48-60, 2009.
66. Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, Rodriguez BL, Shikany JM, Strickler HD, Vitolins MZ, Rohan TE: Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer, 125: 2704-2710, 2009.
67. Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Jeppesen M, Clavel-Chapelon F, Tehard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Arvaniti A, Psaltopoulou T, Trichopoulou A, Palli D, Tumino R, Panico S, Sacerdote C, Sieri S, van Gils CH, Bueno-de-Mesquita BH, Gonzalez CA, Ardanaz E, Larranaga N, Garcia CM, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT, Slimani N, Riboli E, Kaaks R: Serum C-peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer, 119: 659-667, 2006. (Pubitemid 43955721)
68. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351: 1393-1396, 1998. (Pubitemid 28209997)
69. Kaaks R: Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control, 7: 605-625, 1996.
70. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F: Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev, 11: 1361-1368, 2002. (Pubitemid 35340370)
71. Rinaldi S, Toniolo P, Muti P, Lundin E, Zeleniuch-Jacquotte A, Arslan A, Micheli A, Lenner P, Dossus L, Krogh V, Shore RE, Koenig KL, Riboli E, Stattin P, Berrino F, Hallmans G, Lukanova A, Kaaks R: IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. Eur J Cancer Prev, 14: 493-496, 2005. (Pubitemid 41689647)
72. Toniolo P, Bruning PF, Akhmedkhanov A, Bonfrer JM, Koenig KL, Lukanova A, Shore RE, Zeleniuch-Jacquotte A: Serum insulin-like growth factor-I and breast cancer. Int J Cancer, 88: 828-832, 2000.
73. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V: Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis, 20: 41-48, 2010.
74. Bjorge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Haggstrom C, Stattin P, Engeland A: Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev, 19: 1737-1745, 2010.
75. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 285: 2486-2497, 2001.
76. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S: Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer, 119: 236-238, 2006.
77. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol, 20: 42-51, 2002. (Pubitemid 34032594)
78. Irwin M L, Duggan C, Smith A: Fasting C-peptide levels and death due to all causes and breast cancer: The HEAL study. Presented at the AACR Frontiers in Cancer Prevention Conference, National Harbor, MD, November 16-19, 2008. Personal Communication.
79. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, Baumgartner KB, Gilliland FD, Sorensen BE, McTiernan A, Ulrich CM: Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol, 27: 3437-3444, 2009.
80. Micheli A, Meneghini E, Secreto G, Berrino F, Venturelli E, Cavalleri A, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Veronesi U, Formelli F: Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol, 25: 2685-2690, 2007. (Pubitemid 47123174)
81. Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, McTiernan A: Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol, 29: 32-39, 2011.
82. Bolelli G, Muti P, Micheli A, Sciajno R, Franceschetti F, Krogh V, Pisani P, Berrino F: Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev, 4: 509-513, 1995.
83. Micheli A, Muti P, Pisani P, Secreto G, Recchione C, Totis A, Fissi R, Cavalleri A, Panico S, Berrino F: Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. J Clin Epidemiol, 44: 1055-1061, 1991.
84. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE: Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev, 15: 972-978, 2006. (Pubitemid 43823526)
85. Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G, Kaaks R: Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev, 10: 25-33, 2001. (Pubitemid 32106041)
86. Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C, Pala V, Sieri S, Berrino F: Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr, 57: 1079-1088, 2003. (Pubitemid 37121004)
87. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA, 292: 1440-1446, 2004. (Pubitemid 39258336)
88. Carruba G, Granata OM, Pala V, Campisi I, Agostara B, Cusimano R, Ravazzolo B, Traina A: A traditional Mediterranean diet decreases endogenous estrogens in healthy postmenopausal women. Nutr Cancer, 56: 253-259, 2006. (Pubitemid 46417687)
89. Frank LL, Sorensen BE, Yasui Y, Tworoger SS, Schwartz RS, Ulrich CM, Irwin ML, Rudolph RE, Rajan KB, Stanczyk F, Bowen D, Weigle DS, Potter JD, McTiernan A: Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res, 13: 615-625, 2005.
90. McTiernan A, Tworoger SS, Rajan KB, Yasui Y, Sorenson B, Ulrich CM, Chubak J, Stanczyk FZ, Bowen D, Irwin ML, Rudolph RE, Potter JD, Schwartz RS: Effect of exercise on serum androgens in postmenopausal women: a 12- month randomized clinical trial. Cancer Epidemiol Biomarkers Prev, 13: 1099-1105, 2004. (Pubitemid 38917897)
91. McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan KB, Sorensen B, Rudolph RE, Bowen D, Stanczyk FZ, Potter JD, Schwartz RS: Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res, 64: 2923-2928, 2004. (Pubitemid 38500634)
92. Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, Dipietro L, Mayne ST, Yu H: Randomized controlled trial of aerobic exercise on insulin and in-sulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev, 18: 306-313, 2009.
93. Lorincz AM, Sukumar S: Molecular links between obesity and breast cancer. Endocr Relat Cancer, 13: 279-292, 2006. (Pubitemid 43886659)
94. Vainio H, Bianchini F: Weight control and physical activity. Lyon, IARC Handbooks of cancer prevention Vol 6, Lyon, IARC Press, 2002.
95. Norat T, Dossus L, Rinaldi S, Overvad K, Gronbaek H, Tjonneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Boeing H, Lahmann PH, Linseisen J, Nagel G, Trichopoulou A, Trichopoulos D, Kalapothaki V, Sieri S, Palli D, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, van Gils CH, Agudo A, Amiano P, Ardanoz E, Martinez C, Quiros R, Tormo MJ, Bingham S, Key TJ, Allen NE, Ferrari P, Slimani N, Riboli E, Kaaks R: Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr, 61: 91-98, 2007. (Pubitemid 44921120)
96. Qin LQ, He K, Xu JY: Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review. Int J Food Sci Nutr, 60 Suppl 7: 330-340, 2009.
97. McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY: Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring), 14: 1662-1677, 2006. (Pubitemid 46214834)
98. Campbell KL, McTiernan A: Exercise and biomarkers for cancer prevention studies. J Nutr, 137: 161S-169S, 2007. (Pubitemid 46070104)
99. Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R: Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev, 14: 2881-2888, 2005. (Pubitemid 43068820)
100. Eriksson CJ, Fukunaga T, Lindman R: Sex hormone response to alcohol. Nature, 369: 711, 1994.
101. Rinaldi S, Peeters PH, Bezemer ID, Dossus L, Biessy C, Sacerdote C, Berrino F, Panico S, Palli D, Tumino R, Khaw KT, Bingham S, Allen NE, Key T, Jensen MK, Overvad K, Olsen A, Tjonneland A, Amiano P, Ardanaz E, Agudo A, Martinez-Garcia C, Quiros JR, Tormo MJ, Nagel G, Linseisen J, Boeing H, Schulz M, Grobbee DE, Bueno-de-Mesquita HB, Koliva M, Kyriazi G, Thrichopoulou A, Boutron-Ruault MC, Clavel-Chapelon F, Ferrari P, Slimani N, Saracci R, Riboli E, Kaaks R: Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control, 17: 1033-1043, 2006. (Pubitemid 44290768)
102. Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Filippi F, Muggeo M, De Sandre G: Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women. Int J Obes Relat Metab Disord, 20: 206-212, 1996. (Pubitemid 26095352)
103. Holloszy JO, Fontana L: Caloric restriction in humans. Exp Gerontol, 42: 709-712, 2007. (Pubitemid 47058857)
104. Algire C, Amrein L, Bazile M, David S, Zakikhani M, Pollak M: Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo. Oncogene, 30: 1174-1182, 2011.
105. Fontana L, Partridge L, Longo VD: Extending healthy life span-from yeast to humans. Science, 328: 321-326, 2010.
106. Berryman DE, Christiansen JS, Johannsson G, Thorner MO, Kopchick JJ: Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Horm IGF Res, 18: 455-471, 2008.
107. Fontana L, Klein S, Holloszy JO: Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk. Am J Clin Nutr, 84: 1456-1462, 2006. (Pubitemid 44912831)
108. Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO: Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell, 7: 681-687, 2008.
109. Shu L, Cheung KL, Khor TO, Chen C, Kong AN: Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis. Cancer Metastasis Rev, 29: 483-502, 2010.
110. Giampaoli S, Stamler J, Donfrancesco C, Panico S, Vanuzzo D, Cesana G, Mancia G, Pilotto L, Mattiello A, Chiodini P, Palmieri L: The metabolic syndrome: a critical appraisal based on the CUORE epidemiologic study. Prev Med, 48: 525-531, 2009.
111. Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, Venturini M, Morasso G: Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer, 7: 121-127, 1999. (Pubitemid 29187558)
112. Cuzzolaro M, Vetrone G, Marano G, Battacchi M: Body Uneasiness Test. In: Repertorio delle Scale di Valutazione in Psichiatria Firenze, Conti L (Ed), pp 1759-1761, Società Editrice Universo, Rome, 2000.
113. Weiss DS, Marmar CR: The Impact of Event Scale-Revised. In: Assessing Psychological Trauma and PTSD: A Practitioner's Handbook, Wilson J P, Keane T M (Eds.), pp 399-411, Guilford Press, New York, 1997.
114. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand, 67: 361-370, 1983. (Pubitemid 13098606)
115. Foster-Powell K, Holt SH, Brand-Miller JC: International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr, 76: 5-56, 2002. (Pubitemid 34686548)
116. Ostman EM, Liljeberg Elmstahl HG, Bjorck IM: Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr, 74: 96-100, 2001. (Pubitemid 32574916)
117. Trout DL, Hallfrisch J, Behall KM: Atypically high insulin responses to some foods relate to sugars and satiety. Int J Food Sci Nutr, 55: 577-588, 2004. (Pubitemid 40711236)
118. Kushi LH, Cunningham JE, Hebert JR, Lerman RH, Bandera EV, Teas J: The macrobiotic diet in cancer. J Nutr, 131: 3056S-3064S, 2001. (Pubitemid 33070780)
119. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28: 412-419, 1985. (Pubitemid 15018832)
120. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R: EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer, 45: 931-991, 2009.
121. Allemani C, Storm H, Voogd AC, Holli K, Izarzugaza I, Tor-rella- Ramos A, Bielska-Lasota M, Aareleid T, Ardanaz E, Colonna M, Crocetti E, Danzon A, Federico M, Garau I, Grosclaude P, Hedelin G, Martinez-Garcia C, Peignaux K, Plesko I, Primic-Zakelj M, Rachtan J, Tagliabue G, Tumino R, Traina A, Tryggvadottir L, Vercelli M, Sant M: Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study. Eur J Cancer, 46: 1528-1536, 2010.
122. Berrino F, Capocaccia R, Coleman MP, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M, Verdecchia A: Survival of cancer patients in Europe: The EUROCARE-3 study. Ann Oncol, 14: supp 5, v1-v155, 2003.
123. Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin GA, Caan BJ, Flatt SW, Emond JA, Saquib N, Madlensky L, Kealey S, Wasserman L, Thomson CA, Rock CL, Parker BA, Karanja N, Jones V, Hajek RA, Pu M, Mortimer JE: Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial. J Clin Oncol, 27: 352-359, 2009.